EXEL vs RCL · P/E 17, rev $628.7M vs P/E 26, rev $9.28B
Exelixis Inc (EXEL) versus Royal Caribbean Cruises Ltd (RCL) — a side-by-side from cached financials, not a winner call.
Exelixis Inc (EXEL) is a biotechnology company listed on US.
Royal Caribbean Cruises Ltd (RCL) is a travel services company listed on US.
Latest reported EXEL revenue for 2026-07-03 was $628.7M. Net income was $212.1M. Revenue was up 2.9% from 2026-04-03 to 2026-07-03. EXEL currently screens at market cap $12.69B and trailing P/E 16.7.
Latest reported RCL revenue for 2026-06-30 was $9.28B. Net income was $2.07B. RCL currently screens at market cap $85.57B and trailing P/E 25.7.
EXEL currently screens at market cap $12.69B and trailing P/E 16.7. RCL currently screens at market cap $85.57B and trailing P/E 25.7.
Not investment advice. Open the EXEL and RCL stock pages for the full models.
Not investment advice.